Mitchell Mcleod Pugh & Williams Inc Abbott Laboratories Transaction History

Mitchell Mcleod Pugh & Williams Inc

  • $476 Million
  • Q3 2024

A detailed history of Mitchell Mcleod Pugh & Williams Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Mitchell Mcleod Pugh & Williams Inc holds 8,160 shares of ABT stock, worth $955,780. This represents 0.2% of its overall portfolio holdings.

Number of Shares
8,160
Previous 8,159 0.01%
Holding current value
$955,780
Previous $847,000 9.8%
% of portfolio
0.2%
Previous 0.19%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$100.07 - $118.13 $100 - $118
1 Added 0.01%
8,160 $930,000
Q2 2024

Jul 31, 2024
SELL
$100.73 - $112.44 $4,532 - $5,059
-45 Reduced 0.55%
8,159 $847,000
Q1 2024

May 01, 2024
SELL
$109.52 - $120.96 $23,218 - $25,643
-212 Reduced 2.52%
8,204 $932,000
Q4 2023

Feb 05, 2024
SELL
$90.19 - $110.4 $7,125 - $8,721
-79 Reduced 0.93%
8,416 $926,000
Q3 2023

Oct 20, 2023
SELL
$95.53 - $114.62 $38,976 - $46,764
-408 Reduced 4.58%
8,495 $822,000
Q2 2023

Aug 08, 2023
SELL
$100.78 - $112.29 $3,124 - $3,480
-31 Reduced 0.35%
8,903 $970,000
Q1 2023

May 10, 2023
SELL
$96.86 - $114.01 $1,743 - $2,052
-18 Reduced 0.2%
8,934 $904,000
Q4 2022

Feb 03, 2023
SELL
$95.06 - $111.52 $53,708 - $63,008
-565 Reduced 5.94%
8,952 $983,000
Q3 2022

Nov 07, 2022
BUY
$96.76 - $112.03 $24,383 - $28,231
252 Added 2.72%
9,517 $921,000
Q2 2022

Nov 18, 2022
SELL
$102.07 - $123.37 $25,721 - $31,089
-252 Reduced 2.65%
9,265 $1.01 Million
Q1 2022

Apr 26, 2022
BUY
$114.02 - $139.04 $45,608 - $55,616
400 Added 4.51%
9,265 $1.1 Million
Q4 2021

Feb 02, 2022
SELL
$115.53 - $141.46 $1,732 - $2,121
-15 Reduced 0.17%
8,865 $1.25 Million
Q1 2021

May 12, 2021
BUY
$108.84 - $128.23 $5,224 - $6,155
48 Added 0.54%
8,880 $1.06 Million
Q4 2020

Feb 08, 2021
BUY
$105.0 - $114.42 $17,010 - $18,536
162 Added 1.87%
8,832 $967,000
Q3 2020

Oct 27, 2020
BUY
$91.64 - $111.29 $65,064 - $79,015
710 Added 8.92%
8,670 $944,000
Q2 2020

Jul 17, 2020
BUY
$76.57 - $98.0 $108,193 - $138,474
1,413 Added 21.58%
7,960 $728,000
Q1 2020

Apr 08, 2020
SELL
$62.82 - $91.86 $25,128 - $36,744
-400 Reduced 5.76%
6,547 $516,000
Q4 2019

Jan 08, 2020
SELL
$78.51 - $87.4 $12,169 - $13,547
-155 Reduced 2.18%
6,947 $603,000
Q3 2019

Oct 08, 2019
BUY
$81.84 - $88.74 $27,252 - $29,550
333 Added 4.92%
7,102 $594,000
Q3 2018

Oct 09, 2018
SELL
$60.81 - $73.36 $12,162 - $14,672
-200 Reduced 2.87%
6,769 $497,000
Q1 2018

Apr 16, 2018
SELL
$56.27 - $63.62 $11,254 - $12,724
-200 Reduced 2.79%
6,969 $417,000
Q4 2017

Jan 12, 2018
SELL
$53.68 - $57.47 $4,831 - $5,172
-90 Reduced 1.24%
7,169 $409,000
Q3 2017

Oct 12, 2017
BUY
$48.06 - $53.64 $348,867 - $389,372
7,259
7,259 $387,000

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Mitchell Mcleod Pugh & Williams Inc Portfolio

Follow Mitchell Mcleod Pugh & Williams Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email